drugset / Trial / NCT00806026

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

NCT00806026

Phase 3 Completed 731 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This purpose of this study is to investigate the efficacy and tolerability of pregabalin in treating idiopathic RLS patients for up to 12 months.

Timeline

Start
2008-12
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pramipexole Unknown 0.25 mg Oral
Comparator Pramipexole Unknown 0.5 mg Oral
Subject Pregabalin Small molecule 300 mg Oral